Clinical trials
Phase 1 Anemia, Refractory trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 1 |
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 3 |
| Cellerant Therapeutics | 1 |
| Dana-Farber Cancer Institute | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
| M.D. Anderson Cancer Center | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Roswell Park Cancer Institute | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory | 16 |
| Anemia, Refractory, with Excess of Blasts | 13 |
| Myelodysplastic Syndromes | 11 |
| Leukemia | 10 |
| Leukemia, Myelomonocytic, Chronic | 10 |
| Congenital Abnormalities | 6 |
| Leukemia, Myeloid, Acute | 6 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Burkitt Lymphoma | 4 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.